Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1995-06-06
1998-02-24
Ulm, John
Drug, bio-affecting and body treating compositions
Lymphokine
4241841, 4241981, 514 2, 514 8, 514 12, 514885, A61K 3819, C07K 1452
Patent
active
057209529
ABSTRACT:
A method for preparing and isolating a transformation vector containing CSF/cDNA is described. The method comprises:
REFERENCES:
patent: 5078996 (1992-01-01), Conlon et al.
patent: 5147799 (1992-09-01), Bursuker et al.
Wing et al. (1982) J. Clin. Invest. vol. 69, pp. 270-276.
Lusis et al. (1980) Proc. Natl. Acad. Sci. U.S.A. vol. 77, No. 9, pp. 5346-5350.
Yunis, et al., FEBS Letters, 1978, 90: 279-82.
Wu, et al. J. Biol. Chem., 1979, 254: 6226-28.
Gasson, et al. Science, 1984, 226: 1339-1342.
Fojo, et al., Biochemistry, 1978, 17: 3109-16.
Lusis, et al., Blood, 1981, 57: 13-21.
Nicola, et al., Blood, 1979, 54: 614-27.
Fojo, et al., Biophys. Acts., 1977, 494: 92-99.
Price, et al., Biochem. J., 1975, 148: 209-17.
Metcalf, The Hemopoietic Colony Stimulating Factors, Elsevier (1984), pp. 81-84, 215-227, 309-329.
Cohen (1995) Science vol. 270 p. 908.
Clark Steven C.
Kaufman Randal J.
Wong Gordon C.
Mertz Prema
Novartis Corporation
Ulm John
LandOfFree
Method of treating myelo-suppression with GM-CSF does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating myelo-suppression with GM-CSF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating myelo-suppression with GM-CSF will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1873506